Tool for acute kidney injury prediction in hospitalised patients with COVID-19

Authors

  • O.Ya. Antonyuk Bogomolets National Medical University, Kyiv, Ukraine; KAPITAL Ltd. (Medical Centre “Universal Clinic “Oberig”), Kyiv, Ukraine; National Military Medical Clinical Centre “Main Military Clinical Hospital”, Kyiv, Ukraine https://orcid.org/0000-0002-3411-196X

DOI:

https://doi.org/10.22141/2307-1257.14.1.2025.491

Keywords:

mortality, acute kidney injury, pneumonia, C-reactive protein, Padua Prediction Score, lymphocytes, respiratory insufficiency, public health, hospitalisation, outcomes, risk factors, modelling

Abstract

Background. The study focuses on acute kidney injury (AKI) in hospitalised COVID-19 patients. AKI is a significant medical issue often linked to severe conditions like pneumonia and sepsis. Understanding the predictors of AKI in COVID-19 is crucial for improving patient outcomes. Materials and methods. In Kyiv, a retrospective, case-control study was conducted at the KAPITAL Ltd. (Medical Centre “Universal Clinic “Oberig”). The study included 129 patients hospitalised with moderate to severe COVID-19 from 2020 to 2021. They were divided into those who developed AKI (n = 19) and those who did not (n = 110). We used various statistical logistic regression models to predict AKI. Results. Significant predictors of AKI included age, C-reactive protein levels, absolute lymphocyte count, Padua Prediction Score, and respiratory insufficiency. No significant differences were observed in gender distribution, estimated glomerular filtration rate on admission, prevalence of hypertension, diabetes, or body mass index between the two groups. Multivariate logistic regression incorporating the Padua Prediction Score showed strong predictive performance with an AUC of 0.803. Conclusions. The study highlights the critical need for accurate predictive models tailored to specific populations. It aims to develop a novel, region-specific predictive model for AKI in COVID-19 patients by focusing on the Ukrainian population. The model leverages local data to improve risk predictions and patient outcomes, emphasising the importance of early identification and stratification of high-risk individuals.

Downloads

Download data is not yet available.

References

Krzanowska K, Batko K, Niezabitowska K, et al. Predicting acute kidney injury onset with a random forest algorithm using electronic medical records of COVID-19 patients: the CRACoV-AKI model. Pol Arch Intern Med. 2024 May 28;134(5):16697. doi: 10.20452/pamw.16697.

Bajaj T, Koyner JL. Artificial Intelligence in Acute Kidney Injury Prediction. Adv Chronic Kidney Dis. 2022 Sep;29(5):450-460. doi: 10.1053/j.ackd.2022.07.009.

Gruzieva TS, Antonyuk OYa. Analysis of risk factors for severe COVID-19. Počki. 2023;12(1):39-45. doi:10.22141/2307-1257.12.1.2023.393.

Antonyuk OYa. Patient-centered approach to the management of acute kidney injury in the Covid-19 outcomes. Wiad Lek. 2024;77(4):778-783. doi: 10.36740/WLek202404125.

Li D, Ren H, Varelmann DJ, et al. Risk assessment for acute kidney injury and death among new COVID-19 positive adult patients without chronic kidney disease: retrospective cohort study among three US hospitals. BMJ Open. 2022 Feb 21;12(2):e053635. doi: 10.1136/bmjopen-2021-053635.

Diebold M, Schaub S, Landmann E, Steiger J, Dickenmann M. Acute kidney injury in patients with COVID-19: a retrospective cohort study from Switzerland. Swiss Med Wkly. 2021 Mar 1;151:w20482. doi: 10.4414/smw.2021.20482.

Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.

Ivanov DD, Ivanova MD, Crestanello T. Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19). Počki. 2021;10(3):143-149. doi: 10.22141/2307-1257.10.3.2021.239591.

Downloads

Published

2025-03-25

How to Cite

Antonyuk , O. (2025). Tool for acute kidney injury prediction in hospitalised patients with COVID-19. KIDNEYS, 14(1), 24–31. https://doi.org/10.22141/2307-1257.14.1.2025.491

Issue

Section

Original Articles